Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Hoffmann-La Roche

Clinicaltrial registered20 Oct 2026

Hoffmann-La Roche

20 Oct 2026: Trial registered · A Study of RO7821657 in Participants With Solid Tumors. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
20 Oct 2026
Title
A Study of RO7821657 in Participants With Solid Tumors
Conditions
Locally Advanced or Metastatic Solid Tumors
Phase
Phase 1
Study Type
Interventional
Status
Recruiting
Countries
Denmark, United Kingdom
Country
Denmark
Reference
NCT07883577
Location
Denmark, United Kingdom
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Hoffmann-La Roche

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Across AOS Research

Other records for Hoffmann-La Roche in our registers.

More from Denmark

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.